IL6 and COVID-19: The strength of our study lies in the comprehensive dynamics of the pro-inflammatory (mainly IL-1β, IL-6, IL-8, TNF-α) and anti-inflammatory (IL-10) cytokines over time and their comparison with non-severe COVID-19 cases as supporting evidence.